CNR Institutional Research Information System

MARIANI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 124
AS - Asia 48
EU - Europa 9
Totale 181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 124
SG - Singapore 44
FI - Finlandia 6
CN - Cina 4
IT - Italia 2
DE - Germania 1
Totale 181
Salva come PNG Salva come JPEG
Città #
Santa Clara 112
Singapore 34
Helsinki 6
Guangzhou 3
Rome 2
Falkenstein 1
Totale 158
Salva come PNG Salva come JPEG
Nome #
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O-6 methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide 8
Triiodothyronine Prevents Cardiac Ischemia/Reperfusion Mitochondrial Impairment and Cell Loss by Regulating miR30a/p53 Axis 8
Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-beta1 and anti-fibrotic miRNA signaling. 8
null 7
MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. 7
Brief report MicroRNAs modulate the angiogenic properties of HUVECs 7
miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts 7
MicroRNAs modulate the angiogenic properties of HUVECs 7
null 6
null 6
BCL6 and LRF crosstalk in follicular lymphoma 6
miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts 6
null 6
Efficacy of amphipathic oligopeptide to shuttle and release a cis-acting DNA decoy into human cells 6
Holt-Oram syndrome with intermediate atrioventricular canal defect, and aortic coarctation: Functional characterization of a de novo TBX5 mutation 5
MiR-20a and miR-290, multi-faceted players witha role in tumorigenesis and senescence 5
null 5
null 5
A method for prediction of accessible sites an mRNA sequence for target selection of hammerhead ribozymes 5
null 5
Resting smooth muscle cells as a model for studying vascular cell activation 5
miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence. 5
Application of ribozyme strategy to study the sensitivity of breast cancer cells to cytotoxic drugs 5
null 5
null 5
null 5
The over expression of miR-34a in B lymphoma cells neutralizes the proapoptotic/antiproliferative activity of miR-34a through the down regulation of cMYC and the consequent repression of p53 5
Immortalization of MEF is characterized by the deregulation of specific miRNAs with potential tumor suppressor activity 5
The Proto-Oncogene LRF Is under Post-Transcriptional Control of miR-20a: Implications for Senescence 5
MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome 5
null 4
Post-transcriptional modulation of sphingosine-1-phosphate receptor 1 by miR-19a affects cardiovascular development in zebrafish 4
null 4
null 4
null 4
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide 4
The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs 2
The Proto-Oncogene LRF is under Post-Transcriptional Control of MiR-20a:Implications of senescence 2
miR-492 inhibits the angiogenesis in zebrafish (Danio rerio) model 1
The Over-Expression of miR-34a Fails to Block DoHH2 Lymphoma Cell Proliferation by Reducing p53 via c-MYC Down-Regulation 1
Immortalized mouse embryo fibroblasts are resistant to miR-290-induced senescence regardless of p53 status 1
Totale 206
Salva come PNG Salva come JPEG
Categoria #
all - tutte 921
article - articoli 868
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 0 0 3 0
2024/2025203 0 1 38 18 125 21 0 0 0 0 0 0
Totale 206